05/08/2017 - 3:22pm

NACDS and HDA argued importation would threaten and destabilize the significant industry-government collaboration already underway to ensure the security of the supply chain.

05/08/2017 - 2:12pm

Executives from Celgene, Regeneron and Vertex represented the drug industry Monday during a biomedical research discussion, but drug prices, long a concern of President Donald Trump, were not discussed during the two-hour meeting.

05/08/2017 - 9:42am

Research of Mitsubishi Tanabe America drug showed individuals receiving edaravone declined less on a clinical assessment of daily functioning compared to those receiving a placebo.

05/05/2017 - 4:20pm

The clinical-stage biopharmaceutical company listed 9.9 million shares at $17 per share on May 4. 

05/04/2017 - 9:28am

New medicines introduced in the past two years continue to drive at least half of total spending growth as clusters of innovative treatments for cancer, autoimmune diseases, HIV, multiple sclerosis, and diabetes become accessible to patients, according to QuintilesIMS Institute.

05/03/2017 - 2:56pm

Under the collaboration, Pieris will be responsible for advancing its preclinical lead candidate, PRS-060 into Phase I clinical trials this year.

05/03/2017 - 1:18pm

Imfinzi is approved under the FDA’s accelerated approval pathway, based on tumor response rate and durability of response.

05/02/2017 - 4:19pm

Supercenter pharmacy prescription program includes oral generic antibiotics with a special focus on prescriptions most often filled for children, prenatal vitamins, and medications for those with diabetes and high cholesterol.

05/02/2017 - 10:17am

CEO Larry Merlo also points to company’s relationship with OptumRx, PBM contract wins and much more during CVS’ Q1 earnings conference call.